Doctor Evidence CEO Awarded Two Honorary Fellowships

SANTA MONICA, Calif., Nov. 27, 2018 /PRNewswire/ -- Doctor Evidence announces the awarding of two honorary fellowships to Robert Battista, the CEO and co-founder, in recognition for his innovative work in healthcare. The Royal College of Physicians of Edinburgh and the Royal Society for Public Health have conferred these honors on Mr. Battista following nominations from and voting by their respective memberships. He was elected to fellowship in recognition of his substantive contributions to the medical community and career commitment to the improvement of healthcare, particularly uniting otherwise disparate communities in the ecosystem to collaborate for better patient wellbeing.

The Royal College of Physicians of Edinburgh, incorporated by Royal Charter on 29^th Day of November 1681, "brings together an international community of inspirational physicians who strive to ensure that patients receive the highest standards of care by providing lifelong education and training opportunities." 

The Royal Society for Public Health works "to develop and implement a wide range of policy and projects to educate and empower individuals, effect change and celebrate excellence."

These honors recognize the important contributions Mr. Battista has made to the healthcare research community through the development of Doctor Evidence, its GROWTH (Guideline & Research Organizations Worldwide for Transparency & Harmonization) initiatives, and partnerships with organizations like the Institute for Health Metrics Evaluation (IHME). Doctor Evidence is a global technology company offering software, data and services to support medical and health research. The company's goal is to support the efforts of healthcare providers, healthcare professionals, and patients to gain access to important evidence-based knowledge and to improve the health and wellbeing of patients worldwide.

"Five years ago, I was honored to be invited by Bob to help him develop a medical society and academic focused division of the company. This ambitious initiative becameour GROWTH division, that supports our mission to broaden the sharing of resources and data globally across the entire spectrum of healthcare, with the ultimate goal of improving patient outcomes," stated Sandra Zelman Lewis, PhD, Chief Guidelines Officer. "I have enjoyed partnering with a visionary like Bob in this important endeavor. These accolades that he is now receiving are well-deserved."

"I am honored to get these recognitions though it is really the work that our company, Doctor Evidence & GROWTH, have done that has engendered these accolades," said Bob Battista, CEO of Doctor Evidence. "Rarely does everyone associated with a company have an opportunity to use it as a form of personal expression. DRE is a magical place where someone can make an important difference in the lives of healthcare professionals representing our solutions. In this case, I am fortunate to be that 'someone.'"

About Doctor Evidence
Since its founding in 2004, Doctor Evidence, LLC, has been a leader in technological solutions for evidence-based systematic reviews and analyses with a mission to provide stakeholders across the healthcare ecosystem with the most relevant and timely medical evidence and related analytics to make and inform the best clinical decisions. Utilizing state-of-the-art solutions that identify, synthesize, and analyze complex clinical research data, Doctor Evidence provides guideline developers, academic researchers, medical providers, manufacturers, payers, and patients with evidence-based information to make timely and educated decisions on recommended treatment protocols, outcomes research, health economics, risk management, market access, reimbursement, value determinations, and burden of illness cost models.  Doctor Evidence is a global company headquartered in Santa Monica, California.

About GROWTH
The Guideline & Research Organizations Worldwide for Transparency & Harmonization (GROWTH) initiative is committed to improving the health and quality of life of patients by encouraging the development of evidence-based clinical recommendations through collaboration and resource-sharing in all disciplines of medicine and health. GROWTH utilizes Doctor Evidence's cutting-edge platform technologies and services to synthesize high quality data from a broad variety of sources including databases of published clinical studies (e.g., PubMed or EMBASE), clinical trials.gov data, clinical practice guidelines, health technology assessments, systematic reviews, regulatory filings and epidemiological data (e.g., the Global Burden of Disease data from IHME). The resulting knowledge sets are leveraged, utilizing rigorous and transparent methodologies employing sophisticated analytic capabilities, to perform direct meta-analyses, network meta-analyses, meta-regressions, cohort analyses, and sensitivity analyses. These transparent and trusted reviews inform clinical trial designs, guidelines and protocols for patient care, and healthcare policy decisions.

About The Institute for Health Metrics and Evaluation (IHME) 
The Institute for Health Metrics and Evaluation (IHME) is an independent global health research organization at the University of Washington that provides rigorous and comparable measurement of the world's most important health problems and evaluates the strategies used to address them. IHME makes this information widely available so that policymakers have the evidence they need to make informed decisions about how to allocate resources to best improve population health. IHME has been predominantly funded by the Bill and Melinda Gate's Foundation.  The Institute is led by Christopher Murray, MD, who is also the subject of Jeremy Smith's book, Epic Measures, and recent awardee of the Gairdner Prize for Biomedical Research.

View original content:http://www.prnewswire.com/news-releases/doctor-evidence-ceo-awarded-two-honorary-fellowships-300755657.html

SOURCE Doctor Evidence

[ Back To TMCnet.com's Homepage ]